Skip to main content
. 2022 Apr 28;16:833186. doi: 10.3389/fncel.2022.833186

Figure 7.

Figure 7

Hypothesized model of HMGB1 inhibitory activity on OPCs in the MS demyelinated lesion environment. Graphical representation of a demyelinated lesion in the MS brain and how expression of HMGB1 negatively impacts the remyelinating potential of OPCs. The stepwise progression from the MS brain (right) to the demyelinated lesion environment (middle panel) where HMGB1 is expressed at higher concentrations, to the intracellular response of OPCs (right panel) depicting a transcriptional influence of HMGB1 on NFκB gene expression regulation. Results from this study implicate TLR2-mediated receptor activation of NFκB gene target pathways as putative negative regulators of HMGB1 in the MS brain lesion environment. Created with BioRender.